EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 236 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2019. The put-call ratio across all filers is 4.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $20,905,000 | +26.1% | 225,000 | +21.6% | 0.05% | +26.8% |
| Q4 2020 | $16,576,000 | -23.6% | 185,000 | -11.9% | 0.04% | -38.8% |
| Q3 2020 | $21,699,000 | +16.8% | 210,000 | -10.6% | 0.07% | 0.0% |
| Q2 2020 | $18,584,000 | +10.8% | 235,000 | -19.0% | 0.07% | -18.3% |
| Q1 2020 | $16,779,000 | +7.2% | 290,000 | 0.0% | 0.08% | +36.7% |
| Q4 2019 | $15,645,000 | +3.2% | 290,000 | 0.0% | 0.06% | -3.2% |
| Q3 2019 | $15,161,000 | +60.9% | 290,000 | +48.7% | 0.06% | +63.2% |
| Q2 2019 | $9,420,000 | +72.7% | 195,000 | +80.6% | 0.04% | +65.2% |
| Q1 2019 | $5,456,000 | +53.4% | 108,000 | +80.0% | 0.02% | +27.8% |
| Q4 2018 | $3,557,000 | -9.9% | 60,000 | 0.0% | 0.02% | +12.5% |
| Q3 2018 | $3,950,000 | +30.4% | 60,000 | 0.0% | 0.02% | +23.1% |
| Q2 2018 | $3,029,000 | +27.9% | 60,000 | +33.3% | 0.01% | +18.2% |
| Q1 2018 | $2,369,000 | +13.3% | 45,000 | 0.0% | 0.01% | +10.0% |
| Q4 2017 | $2,091,000 | – | 45,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |